Amit Singal, M.D.

Dallas Hepatologist

Amit Singal, M.D., M.S., has declared war on liver cancer, which is the ninth leading cause of cancer-related death in the U.S. and the fastest-growing cancer in Texas.

“I’m going to work as hard as I can to give my patients the care they deserve,” he says. “Cancer patients want a doctor who cares and will go the extra mile. I’m dedicated to doing that.”

A hepatologist, Dr. Singal treats patients with liver cancer and other liver diseases. He is a Professor of Internal Medicine in the Division of Digestive and Liver Diseases at UT Southwestern Medical Center. Additionally, he serves as Medical Director of the UT Southwestern Liver Tumor Program and as Clinical Chief of Hepatology.

A native of the Detroit area, Dr. Singal came to Texas and UT Southwestern so he could help do something about liver cancer in the Lone Star State. Texas has the highest incidence rate of liver cancer in the nation, and he believes that it will only become an increasingly more important problem over the next two decades. Dr. Singal believes UT Southwestern has the cutting-edge therapies and committed doctors who can make a difference in this field.

Most of his research examines how to diagnose and treat liver cancer when curative therapies are still possible. He believes it is important to work with primary care physicians and other hepatologists to follow published guidelines for liver cancer screening among at-risk patients. People with liver diseases who are at risk for liver cancer should get screened every six months, but fewer than 25% of patients are currently having this done. Dr. Singal’s goal is to improve this care over the next several years.

“If we diagnose liver cancer at an early stage, we can often cure it,” he says. “Patients can live over five years if we diagnose and treat liver cancer early. However, when it’s found at a late stage, the average survival is typically less than one year.”

Dr. Singal works closely with patients to help them choose the best treatment options, and he is willing to do whatever it takes to get his patients through the process.

He is hopeful about new advances in medicine.

“We’ve made incredible strides in treatments for liver cancer already over the past decade,” he notes. “Over the next decade, we will see even more advances in therapeutic options for this cancer.”